32
https://pubmed.ncbi.nlm.nih.gov/38113421
The level of RNA disruption during neoadjuvant chemotherapy can predict the absence of a pathologic complete response in breast cancer patients.
https://pubmed.ncbi.nlm.nih.gov/38113421
The level of RNA disruption during neoadjuvant chemotherapy can predict the absence of a pathologic complete response in breast cancer patients.